Di Leo A - Search Results

1

New approaches for improving outcomes in breast cancer in Europe.

Di Leo A, Curigliano G, Diéras V, Malorni L, Sotiriou C, Swanton C, Thompson A, Tutt A, Piccart M. Di Leo A, et al. Breast. 2015 Aug;24(4):321-30. doi: 10.1016/j.breast.2015.03.001. Epub 2015 Mar 31. Breast. 2015. PMID: 25840656 Free article. Review.

2

Future perspectives of docetaxel (Taxotere) in front-line therapy.

Piccart MJ, Di Leo A. Piccart MJ, et al. Among authors: di leo a. Semin Oncol. 1997 Aug;24(4 Suppl 10):S10-27-S10-33. Semin Oncol. 1997. PMID: 9275004 Review.

3

HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil.

Di Leo A, Gancberg D, Larsimont D, Tanner M, Jarvinen T, Rouas G, Dolci S, Leroy JY, Paesmans M, Isola J, Piccart MJ. Di Leo A, et al. Clin Cancer Res. 2002 May;8(5):1107-16. Clin Cancer Res. 2002. PMID: 12006526 Clinical Trial.

4

3-year results of docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer: a pilot study.

Ferreira Filho AF, Crown J, Cardoso F, Nogaret JM, Duffy K, Dolci S, Rowan S, O'Higgins N, Batter V, Paesmans M, Piccart MJ, Di Leo A. Ferreira Filho AF, et al. Among authors: di leo a. Anticancer Res. 2002 Jul-Aug;22(4):2471-6. Anticancer Res. 2002. PMID: 12174946 Clinical Trial.

5

HER-2/neu evaluation by immunohistochemistry and fluorescence in situ hybridization in breast cancer: implications for daily laboratory practice.

Larsimont D, Di Leo A, Rouas G, Paesmans M, Ferreira-Filho F, Bernard C, Cardoso F, Verhest A, Piccart MJ, Gancberg D. Larsimont D, et al. Among authors: di leo a. Anticancer Res. 2002 Jul-Aug;22(4):2485-90. Anticancer Res. 2002. PMID: 12174949

6

Evaluation of HER-2/NEU protein expression in breast cancer by immunohistochemistry: an interlaboratory study assessing the reproducibility of HER-2/NEU testing.

Gancberg D, Järvinen T, di Leo A, Rouas G, Cardoso F, Paesmans M, Verhest A, Piccart MJ, Isola J, Larsimont D. Gancberg D, et al. Among authors: di leo a. Breast Cancer Res Treat. 2002 Jul;74(2):113-20. doi: 10.1023/a:1016146130767. Breast Cancer Res Treat. 2002. PMID: 12186371

7

Predictive molecular markers in the adjuvant therapy of breast cancer: state of the art in the year 2002.

Di Leo A, Cardoso F, Durbecq V, Giuliani R, Mano M, Atalay G, Larsimont D, Sotiriou C, Biganzoli L, Piccart MJ. Di Leo A, et al. Int J Clin Oncol. 2002 Aug;7(4):245-53. doi: 10.1007/s101470200036. Int J Clin Oncol. 2002. PMID: 12202978 Review.

8

Resistance to trastuzumab: a necessary evil or a temporary challenge?

Cardoso F, Piccart MJ, Durbecq V, Di Leo A. Cardoso F, et al. Among authors: di leo a. Clin Breast Cancer. 2002 Oct;3(4):247-57; discussion 258-9. doi: 10.3816/CBC.2002.n.028. Clin Breast Cancer. 2002. PMID: 12425752 Review.

9

The European experience with docetaxel in the treatment of early-stage breast cancer.

Di Leo A. Di Leo A. Clin Breast Cancer. 2002 Oct;3 Suppl 2:S59-62. doi: 10.3816/cbc.2002.s.013. Clin Breast Cancer. 2002. PMID: 12435289 Review.

10

Controversies in the adjuvant systemic therapy of endocrine-non-responsive breast cancer.

Cardoso F, Di Leo A, Piccart MJ. Cardoso F, et al. Among authors: di leo a. Cancer Treat Rev. 2002 Dec;28(6):275-90. doi: 10.1016/s0305-7372(02)00091-9. Cancer Treat Rev. 2002. PMID: 12470979 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

792 results

Search Page

Filters